319 related articles for article (PubMed ID: 23329387)
1. Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.
Hummel TR; Chow LM; Fouladi M; Franz D
Paediatr Drugs; 2013 Feb; 15(1):29-42. PubMed ID: 23329387
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors in children with malignant gliomas.
Herrington B; Kieran MW
Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
[TBL] [Abstract][Full Text] [Related]
3. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
4. Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
Moorman B; Barbour M; Huang MA
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e141-e145. PubMed ID: 33235141
[TBL] [Abstract][Full Text] [Related]
5. Invasion is not an independent prognostic factor in high-grade glioma.
Narayana A; Perretta D; Kunnakkat S; Gruber D; Golfinos J; Parker E; Medabalmi P; Zagzag D; Pat Eagan RN; Gruber M
J Cancer Res Ther; 2011; 7(3):331-5. PubMed ID: 22044816
[TBL] [Abstract][Full Text] [Related]
6. The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective.
Finlay JL; Zacharoulis S
J Neurooncol; 2005 Dec; 75(3):253-66. PubMed ID: 16195805
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
Sturm D; Pfister SM; Jones DTW
J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
[TBL] [Abstract][Full Text] [Related]
8. Treatment of high-grade glioma in children and adolescents.
MacDonald TJ; Aguilera D; Kramm CM
Neuro Oncol; 2011 Oct; 13(10):1049-58. PubMed ID: 21784756
[TBL] [Abstract][Full Text] [Related]
9. An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.
Kyritsis AP; Levin VA
Cancer Chemother Pharmacol; 2011 May; 67(5):971-83. PubMed ID: 21442438
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab in recurrent high-grade pediatric gliomas.
Narayana A; Kunnakkat S; Chacko-Mathew J; Gardner S; Karajannis M; Raza S; Wisoff J; Weiner H; Harter D; Allen J
Neuro Oncol; 2010 Sep; 12(9):985-90. PubMed ID: 20363768
[TBL] [Abstract][Full Text] [Related]
11. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy for high-grade gliomas.
Chamberlain MC; Raizer J
CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):184-94. PubMed ID: 19601816
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy in the treatment of high grade gliomas.
Lonardi S; Tosoni A; Brandes AA
Cancer Treat Rev; 2005 Apr; 31(2):79-89. PubMed ID: 15847978
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy in pediatric low-grade glioma.
Kilday JP; Bartels UK; Bouffet E
Curr Neurol Neurosci Rep; 2014 Apr; 14(4):441. PubMed ID: 24604059
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma.
Drappatz J; Lee EQ; Hammond S; Grimm SA; Norden AD; Beroukhim R; Gerard M; Schiff D; Chi AS; Batchelor TT; Doherty LM; Ciampa AS; Lafrankie DC; Ruland S; Snodgrass SM; Raizer JJ; Wen PY
J Neurooncol; 2012 Mar; 107(1):133-8. PubMed ID: 21984064
[TBL] [Abstract][Full Text] [Related]
17. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.
Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056
[TBL] [Abstract][Full Text] [Related]
18. Cilengitide in bevacizumab-refractory high-grade glioma: two case reports and critical review of the literature.
Lombardi G; Zustovich F; Farina P; Polo V; Farina M; Della Puppa A; Bertorelle R; Gardiman MP; Berti F; Zagonel V
Anticancer Drugs; 2012 Aug; 23(7):749-53. PubMed ID: 22382388
[TBL] [Abstract][Full Text] [Related]
19. Thalamic high-grade gliomas in children: a distinct clinical subset?
Kramm CM; Butenhoff S; Rausche U; Warmuth-Metz M; Kortmann RD; Pietsch T; Gnekow A; Jorch N; Janssen G; Berthold F; Wolff JE
Neuro Oncol; 2011 Jun; 13(6):680-9. PubMed ID: 21636712
[TBL] [Abstract][Full Text] [Related]
20. Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas.
Chamberlain MC
Cancer; 2010 Sep; 116(17):3988-99. PubMed ID: 20564141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]